AAM
SUPN icon

Azzad Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Azzad Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,147
Closed -$540K – 357
2025
Q2 		$540K Buy
17,147
+300
+2% +$9.61K 0.06% 267
2025
Q1 		$552K Buy
+16,847
New +$597K 0.07% 260
2024
Q4 		– Sell
-15,641
Closed -$488K – 294
2024
Q3 		$488K Sell
15,641
-96
-0.6% -$3K 0.05% 275
2024
Q2 		$421K Buy
15,737
+40
+0.3% +$1.16K 0.05% 270
2024
Q1 		$535K Buy
15,697
+29
+0.2% +$863 0.06% 265
2023
Q4 		$453K Buy
15,668
+199
+1% +$5.28K 0.06% 277
2023
Q3 		$426K Buy
15,469
+350
+2% +$10.7K 0.06% 272
2023
Q2 		$454K Buy
15,119
+304
+2% +$10.6K 0.06% 282
2023
Q1 		$537K Buy
14,815
+254
+2% +$9.77K 0.08% 266
2022
Q4 		$519K Buy
14,561
+72
+0.5% +$2.5K 0.08% 263
2022
Q3 		$490K Sell
14,489
-101
-0.7% -$3.29K 0.05% 342
2022
Q2 		$422K Buy
14,590
+1,823
+14% +$52.2K 0.04% 345
2022
Q1 		$413K Sell
12,767
-7,436
-37% -$228K 0.06% 282
2021
Q4 		$589K Sell
20,203
-265
-1% -$8.04K 0.08% 281
2021
Q3 		$546K Buy
20,468
+4,308
+27% +$116K 0.08% 283
2021
Q2 		$498K Sell
16,160
-204
-1% -$6.25K 0.07% 284
2021
Q1 		$428K Buy
+16,364
New +$458K 0.07% 282

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Azzad Asset Management's SUPN Position: Q3 2025 in Review

Azzad Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 17,147 shares — an estimated $540K sold.

Azzad Asset Management first reported a position in SUPN in Q1 2021 and held it in 17 quarters. The position peaked at $589K in Q4 2021. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Azzad Asset Management reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Azzad Asset Management sold 17,147 Supernus Pharmaceuticals shares in Q3 2025, an estimated $540K.
  • Azzad Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 17 quarters.
  • Azzad Asset Management's Supernus Pharmaceuticals position peaked at $589K in Q4 2021.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Azzad Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.